10x Genomics Inc. (TXG) News
Filter TXG News Items
TXG News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
TXG News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest TXG News From Around the Web
Below are the latest news stories about 10X GENOMICS INC that investors may wish to consider to help them evaluate TXG as an investment opportunity.
Colorado’s Most Expensive Home for Sale Is Listing for $78 MillionA home in Vail, Colo., is slated to go on the market for $78 million, making it the state’s most expensive listing. If the roughly 15,100-square-foot home sells at or near its asking price, it will break its own record for the ski town’s priciest sale, set when it traded for $57.25 million in 2020, according to listing agent Tye Stockton of Compass. The sellers are Kevin Ness, a Colorado biotech entrepreneur, and his wife, Stephanie Ness. |
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time. |
Bruker seeks to pause injunction of GeoMx in the US after court rulingA US court previously found that NanoString – acquired by Bruker earlier this year – infringed on patented technology developed by 10x Genomics. |
Update: 10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US(Updates with Bruker's statement in the sixth and seventh paragraphs.) 10x Genomics (TXG) said la |
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtThe aggressive growth fund investor has slowed her shopper this holiday season, but she still made time to build up some of her existing positions. |
10x Genomics Secures Court Injunction Against Bruker's Sale of GeoMx Products in US10x Genomics (TXG) said late Monday a US court issued a permanent injunction against the sale of Geo |
U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S. District Court for the District of Delaware against the GeoMx products sold by Bruker Corporation (Nasdaq: BRKR), which acquired the product line from NanoString Technologies. To minimize the risk of disruption to ongoing research, 10x Genomics requested a carve-out for GeoMx users who installed an instrument prior to the trial in November 2023. |
If RFK Jr. Cuts Science Funding, These Instrument Makers May SufferKennedy would oversee the National Institutes of Health as head of the Department of Health and Human Services. |
10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right NowWe recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at where 10x Genomics, Inc. (NASDAQ:TXG) stands against the other genomics stocks. Genomics is the study of genes and how they function. Many rapidly growing companies are emerging in the genomics […] |
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Wolfe Research 2024 Healthcare Conference on Tuesday, November 19, at 1:00 p.m. Eastern Time. |